Dabigatran Levels in Elderly Patients with Atrial Fibrillation: First Post-Marketing Experiences

Tomáš Bolek1, Matej Samoš2, Ingrid Škorňová3

  • 1Department of Internal Medicine I, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59, Martin, Slovak Republic.

Drugs & Aging
|May 9, 2018
PubMed

Insights

Elderly patients with non-valvular atrial fibrillation (NV-AF) on reduced dabigatran doses show higher drug levels than younger patients on the same dose. These levels are comparable to younger patients on standard dabigatran doses.

Area of Science:

  • Pharmacology
  • Geriatrics
  • Cardiology

Background:

  • The prevalence of non-valvular atrial fibrillation (NV-AF) is increasing in the elderly population.
  • Pharmacokinetics of oral anticoagulants may differ in elderly patients.
  • This study investigates dabigatran levels in elderly NV-AF patients.

Purpose of the Study:

  • To assess dabigatran plasma concentrations in elderly patients with NV-AF.
  • To compare dabigatran levels between elderly and younger NV-AF patients on different dosage regimens.
  • To evaluate the impact of age on dabigatran pharmacokinetics.

Main Methods:

  • Pilot prospective post-marketing study design.
  • Inclusion of 21 elderly (≥75 years) and 29 younger (≤70 years) NV-AF patients.
  • Measurement of dabigatran trough and peak levels using Hemoclot® Thrombin Inhibitor Assay.

Main Results:

  • Elderly patients on reduced dabigatran (110 mg BID) had significantly higher trough (99.3 ± 73.6 ng/mL) and peak (173.4 ± 116.2 ng/mL) levels compared to younger patients on reduced doses (51.6 ± 25.6 ng/mL and 116.1 ± 19.1 ng/mL, respectively).
  • No significant differences in dabigatran levels were observed between elderly patients on reduced doses and younger patients on standard doses (150 mg BID).

Conclusions:

  • Elderly patients on reduced dabigatran regimens exhibit higher drug exposure than younger patients on similar reduced doses.
  • Dabigatran exposure in elderly patients on reduced doses is comparable to younger patients on standard doses.
  • These findings highlight potential pharmacokinetic differences in elderly patients requiring anticoagulation therapy.
Abstract

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Amyloid Fibrils03:03

Amyloid Fibrils

6.5K
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.4K
What is an Experiment?01:12

What is an Experiment?

An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
19.1K
Leveling Effect01:29

Leveling Effect

In acid-base chemistry, the leveling effect refers to the limitation imposed by the solvent on the strength of acids and bases in solution. When a base stronger than the solvent's conjugate base is used, it deprotonates the solvent until the base is entirely consumed, making it ineffective against weaker acids. Conversely, an acid stronger than the solvent's conjugate acid protonates the solvent until the acid is depleted, rendering it ineffective against weaker bases. Essentially, the...
1.4K
The Stanford Prison Experiment03:20

The Stanford Prison Experiment

The famous and controversial Stanford Prison Experiment, conducted by social psychologist Philip Zimbardo and his colleagues at Stanford University, demonstrated the power of social roles, social norms, and scripts.
24.8K